Safety of multicomponent meningococcal group B vaccine
The Lancet Child & Adolescent Health in conversation with
English - April 26, 2018 06:30 - 9 minutes - 6.27 MBLife Sciences Science Education child adolescent pediatrics pediatrician young Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Adolescent-to-parent abuse
Next Episode: Treatment of paediatric narcolepsy with sodium oxybate
Philip Bryan joins The Lancet Child & Adolescent Health to discuss the safety of multicomponent meningococcal group B vaccine (4CMenB) in the UK’s infant immunisation programme.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv